Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

Synergistic Activity of the MCL-1 Inhibitor S63845 with Midostaurin in Preclinical Human Models of FLT3- ITD Mutated AML - Inhibiton of Mcl-1 Improves Anti-Leukemia Efficacy

21 views
October 18, 2019
0 Comments
Login to view comments. Click here to Login